Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 4, 2002, Pages 1509-1516

  Dobs, Adrian S ^a,c   Nguyen, Tam ^a,c   Pace, Cindy ^a,b   Roberts, Carla P ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Solvay Pharmaceuticals Inc   (Netherlands)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; ESTRATEST; ESTROGEN; METHYLTESTOSTERONE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; LEAN BODY WEIGHT; MUSCLE STRENGTH; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; SIDE EFFECT;

EID: 0036280959     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.4.8362     Document Type: Article

References (58)

1. The relationship of menopause to skeletal and muscle mass
2. The effect of menopause on regional and total body lean mass
3. Aging, body composition and lifestyle: The Fels longitudinal study
4. Fat or lean tissue mass: Which one is the major determinant of bone mineral mass in healthy postmenopausal women?
5. Menopause, central body fatness and insulin resistance: Effects of hormone replacement therapy
6. The minimum effective dose of estrogen for prevention of postmenopausal bone loss
7. Treatment of postmenopausal osteoporosis
8. Estrogen replacement therapy in older women: Comparisons between Alzheimer's disease cases and nondemented control subjects
9. Hormone therapy to prevent disease and prolong life in postmenopausal women
10. Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women
11. Impact of hormone replacement therapy on body mass and fat compositions of menopausal women: A cross-sectional study
12. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause
13. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass
14. Maximal muscle strength of elderly women is not influenced by estrogen status
15. Is postmenopausaI estrogen therapy associated with neuromuscular function or falling in elderly women?
16. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women
17. The climacteric ovary as a functional gonadotropin-driven and androgen-producing gland
18. The hormonal activity of the postmenopausal ovary
19. Androgen therapy in gynecology
20. Low-dosage androgen-estrogen therapy in the older age group. Symposium presentation
21. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women
22. Differential symptom response to parenteral estrogen and or androgen administration in surgical menopause
23. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women
24. Differential effects of estrogen-androgen and estrogen only therapy on vasomotor symptoms, gonadotropin secretion, endogenous androgen biovailability in postmenopausal women
25. Testosterone enhances estradiol effects on postmenopausal bone density and sexuality
26. A two-year double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women: Effects on bone mineral density, symptoms and lipid profiles
27. Soft tissue body composition during prevention and treatment of postmenopausal osteoporosis assessed by photon absorptiometry
28. Changes in body composition following therapy of osteoporosis with methandrostenolone
29. Effect of percutaneous androgen replacement therapy on body composition and body weight in postmenopausal women
30. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: A pilot study
31. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men
32. Fat free mass by bioelectrical impedance vs dual energy x-ray absorptiometry
33. Technical principals of dual energy x-ray absorptiometry
34. Validation of measurement of body composition from whole body bioelectric impedance analysis
35. Determination of whole body composition from whole body electrical impedance
36. Self-report assessment of female sexual function: Pyschometric evaluation of Brief Index of Sexual Functioning for Women
37. Measuring sexual functioning in premenopausal women
38. Sexual interest and functioning in postmenopausal women: A community-based national survey
39. Clinical testing and preliminary validation of an androgen-sensitive menopausal quality of life scale (QUALMS)
40. Testosterone, body composition and aging
41. Treatment guidelines for HIV-associated wasting
42. Abdominal obesity and its metabolic complications: Implications for the risk of isehemic heart disease
43. Regional obesity and risk of cardiovascular disease; the Framingham study
44. Effect of disuse on bone mineral density content, lean mass and fat mass in osteoarthritic patients
45. Dual-energy x-ray absorptiometry body composition model: Review of physical concepts
46. Dual-energy x-ray absorptiometry: Fat estimation errors due to variation in soft tissue hydration
47. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
48. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels
49. Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States
50. Liver function in postmenopausal women on estrogen-androgen hormone replacement therapy: A meta-analysis of eight clinical trials
51. Androgen and estrogen-androgen hormone replacement therapy: A review of safety literature 1941-1996
52. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status
53. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
54. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines
55. Triglyceride as a risk factor for coronary artery disease
56. Preventing coronary heart disease in women: Brief observation from the clinical data
57. Epidemiology of hypertriglyceridemia and cardiovascular disease
58. The role of androgen in the maintenance of sexual functioning in oophorectomized women